Zealthy and Ro both offer FDA-approved, generic GLP-1s at personalized dosages to fit your needs. These platforms also have a ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

The government-funded study was small and experts say it's not yet clear how safe these drugs are for people who don't need ...

Covering some 1.9million people in the UK, private health insurer Vitality has become the country’s first provider to offer ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

Angie from Milwaukee Medical Weight Loss & Medispa is here today to chat about how weight loss injectables are a game changer for people and her practice.

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...